Generic placeholder image

Recent Advances in Anti-Infective Drug Discovery

Editor-in-Chief

ISSN (Print): 2772-4344
ISSN (Online): 2772-4352

Research Article

Synthesis, Antibacterial, and Cytotoxicity Evaluation of Oleanolic Acid-4-aminoquinoline Based Hybrid Compounds

Author(s): Vuyolwethu Khwaza , Opeoluwa O. Oyedeji , Blessing A. Aderibigbe*, Eric Morifi, Thierry Y. Fonkui, Derek T. Ndinteh and Vanessa Steenkamp

Volume 16 , Issue 2 , 2021

Published on: 10 February, 2021

Page: [122 - 136] Pages: 15

DOI: 10.2174/1574891X16666210210165547

Price: $65

Abstract

Aim: The study aims to prepare a class of oleanolic-based compounds.

Background: Conventional drugs used to treat infectious diseases suffer from limitations such as drug toxicity and drug resistance. The resistance of microbes to antimicrobial agents is a significant challenge in treating microbial infections. Combining two or more drugs with different modes of action to treat microbial infections results in a delay in developing drug resistance by the microbes. However, it is challenging to select the appropriate drugs for combination therapy due to the differences in stability and pharmacokinetic profile of the drugs. Therefore, developing hybrid compounds using the existing drugs is a promising approach to design effective antimicrobial agents.

Objectives: To prepare oleanolic-based hybrid compounds followed by characterization, in vitro antibacterial and cytotoxicity evaluation.

Methods: Oleanolic acid-4-aminoquinoline-based hybrid compounds were synthesized via esterification and amidation. The compounds were characterized using FTIR, NMR, and UHPLC-HRMS. Oleanolic acid (OA) was isolated from the flower buds of Syzygium aromaticum (L.) Merr. & L.M.Perry, a species from Kingdom Plantae, order Mytales in the Myrtaceae family. Antibacterial activity was determined against selected strains of bacteria using the microdilution assay and cytotoxicity activity was assessed using the sulforhodamine B assay against selected cancer cell lines.

Results: The synthesized hybrid compounds exhibited antibacterial activity against the Gram-positive bacteria Enterococcus faecalis (ATCC13047), Bacillus subtilis (ATCC19659), Staphylococcus aureus as well as Gram-negative bacteria, Klebsiella oxytoca (ATCC8724), Escherischia coli (ATCC25922), and Proteus vulgaris (ATCC6380) with minimum inhibitory concentrations of 1.25 mg/mL compared to oleanolic acid (2.5 mg/mL). Compounds 13 and 14 displayed cytotoxicity in vitro against the cancer cell lines (MCF-7 and DU 145) compared to the oleanolic acid (IC50 ˃ 200 μM).

Conclusion: Modification of C28 of OA enhanced its biological activity.

Keywords: Syzygium aromaticum, oleanolic acid, 4-aminoquinoline derivatives, antibacterial activity, cytotoxicity, hybrid compounds.

Next »
Graphical Abstract
[1]
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2095-128.
[http://dx.doi.org/10.1016/S0140-6736(12)61728-0] [PMID: 23245604]
[2]
Walvekar P, Gannimani R, Govender T. Combination drug therapy via nanocarriers against infectious diseases. Eur J Pharm Sci 2019; 127: 121-41.
[http://dx.doi.org/10.1016/j.ejps.2018.10.017] [PMID: 30342173]
[3]
Taganna JC, Quanico JP, Perono RMG, Amor EC, Rivera WL. Tannin-rich fraction from Terminalia catappa inhibits quorum sensing (QS) in Chromobacterium violaceum and the QS-controlled biofilm maturation and LasA staphylolytic activity in Pseudomonas aeruginosa. J Ethnopharmacol 2011; 134(3): 865-71.
[http://dx.doi.org/10.1016/j.jep.2011.01.028] [PMID: 21291979]
[4]
Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis 2011; 11(9): 692-701.
[http://dx.doi.org/10.1016/S1473-3099(11)70054-8] [PMID: 21659004]
[5]
Centers for Disease Control and prevention (CDC). Available on: https://www.cdc.gov/drugresistance/biggest_threats.html.
[6]
Karagöz AÇ, Leidenberger M, Hahn F, et al. Synthesis of new betulinic acid/betulin-derived dimers and hybrids with potent antimalarial and antiviral activities. Bioorg Med Chem 2019; 27(1): 110-5.
[http://dx.doi.org/10.1016/j.bmc.2018.11.018] [PMID: 30503412]
[7]
Srivastava V, Lee H. Chloroquine-based hybrid molecules as promising novel chemotherapeutic agents. Eur J Pharmacol 2015; 762: 472-86.
[http://dx.doi.org/10.1016/j.ejphar.2015.04.048] [PMID: 25959387]
[8]
Nqoro X, Tobeka N, Aderibigbe BA. Quinoline-based hybrid compounds with antimalarial activity. Molecules 2017; 22(12): 2268.
[http://dx.doi.org/10.3390/molecules22122268] [PMID: 29257067]
[9]
Sommerwerk S, Heller L, Kuhfs J, Csuk R. Selective killing of cancer cells with triterpenoic acid amides - The substantial role of an aromatic moiety alignment. Eur J Med Chem 2016; 122: 452-64.
[http://dx.doi.org/10.1016/j.ejmech.2016.06.053] [PMID: 27416552]
[10]
Kurek A, Nadkowska P, Pliszka S, Wolska KI. Modulation of antibiotic resistance in bacterial pathogens by oleanolic acid and ursolic acid. Phytomedicine 2012; 19(6): 515-9.
[http://dx.doi.org/10.1016/j.phymed.2011.12.009] [PMID: 22341643]
[11]
Kuźma Ł, Rózalski M, Walencka E, Rózalska B, Wysokińska H. Antimicrobial activity of diterpenoids from hairy roots of Salvia sclarea L.: salvipisone as a potential anti-biofilm agent active against antibiotic resistant Staphylococci. Phytomedicine 2007; 14(1): 31-5.
[http://dx.doi.org/10.1016/j.phymed.2005.10.008] [PMID: 17190643]
[12]
Chouaïb K, Hichri F, Nguir A, et al. Semi-synthesis of new antimicrobial esters from the natural oleanolic and maslinic acids. Food Chem 2015; 183: 8-17.
[http://dx.doi.org/10.1016/j.foodchem.2015.03.018] [PMID: 25863603]
[13]
Cui HW, He Y, Wang J, et al. Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents. Eur J Med Chem 2015; 95: 240-8.
[http://dx.doi.org/10.1016/j.ejmech.2015.03.048] [PMID: 25817774]
[14]
Thi TAD, Tuyet NTK, The CP, et al. Synthesis and cytotoxic evaluation of novel amide-triazole-linked triterpenoid-AZT conjugates. Tetrahedron Lett 2015; 56: 218-24.
[http://dx.doi.org/10.1016/j.tetlet.2014.11.069]
[15]
Venugopal K, Rather HA, Rajagopal K, et al. Synthesis of silver nanoparticles (Ag NPs) for anticancer activities (MCF 7 breast and A549 lung cell lines) of the crude extract of Syzygium aromaticum. J Photochem Photobiol B 2017; 167: 282-9.
[http://dx.doi.org/10.1016/j.jphotobiol.2016.12.013] [PMID: 28110253]
[16]
Aisha AFA, Abu-salah KM, Salman A. Syzygium aromaticum extracts as good source of betulinic acid and potential anti-breast cancer. Brazilian J Pharmacogn 2012; 22: 335-43.
[http://dx.doi.org/10.1590/S0102-695X2011005000185]
[17]
El-Maati MFA, Mahgoub SA, Labib SM, Al-Gaby AMA, Ramadan MF. Phenolic extracts of clove (Syzygium aromaticum) with novel antioxidant and antibacterial activities. Eur J Integr Med 2016; 8: 494-504.
[http://dx.doi.org/10.1016/j.eujim.2016.02.006]
[18]
Sobeh M, Esmat A, Petruk G, et al. Phenolic compounds from Syzygium jambos (Myrtaceae) exhibit distinct antioxidant and hepatoprotective activities in vivo. J Funct Foods 2018; 41: 223-31.
[http://dx.doi.org/10.1016/j.jff.2017.12.055]
[19]
Wang YF, Jia JX, Tian YQ, et al. Antifungal effects of clove oil microcapsule on meat products. Lebensm Wiss Technol 2018; 89: 604-9.
[http://dx.doi.org/10.1016/j.lwt.2017.11.042]
[20]
Hasheminejad N, Khodaiyan F, Safari M. Improving the antifungal activity of clove essential oil encapsulated by chitosan nanoparticles. Food Chem 2019; 275: 113-22.
[http://dx.doi.org/10.1016/j.foodchem.2018.09.085] [PMID: 30724177]
[21]
Shukri R, Mohamed S, Mohamed N. Cloves protect the heart, liver and lens of diabetic rats. Food Chem 2010; 122: 1116-21.
[http://dx.doi.org/10.1016/j.foodchem.2010.03.094]
[22]
Zhong Y, Chen H. Wu b, P.; Zhang, B.; Yang, Y.; Zhu, Q.; Zhang, C.; Zhao, S. Synthesis and biological evaluation of novel ursolic acid analogues as potential α-glucosidase inhibitors. Eur J Med Chem 2019; 164: 706-16.
[http://dx.doi.org/10.1016/j.ejmech.2018.12.046] [PMID: 30677669]
[23]
Siewert B, Pianowski E, Csuk R. Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28. Eur J Med Chem 2013; 70: 259-72.
[http://dx.doi.org/10.1016/j.ejmech.2013.10.016] [PMID: 24161703]
[24]
Swidorski JJ, Liu Z, Sit SY, et al. Inhibitors of HIV-1 maturation: Development of structure-activity relationship for C-28 amides based on C-3 benzoic acid-modified triterpenoids. Bioorg Med Chem Lett 2016; 26(8): 1925-30.
[http://dx.doi.org/10.1016/j.bmcl.2016.03.019] [PMID: 26988305]
[25]
Zhou M, Zhang RH, Wang M, Xu GB, Liao SG. Prodrugs of triterpenoids and their derivatives. Eur J Med Chem 2017; 131: 222-36.
[http://dx.doi.org/10.1016/j.ejmech.2017.03.005] [PMID: 28329729]
[26]
Qiu WW, Shen Q, Yang F, et al. Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B. Bioorg Med Chem Lett 2009; 19(23): 6618-22.
[http://dx.doi.org/10.1016/j.bmcl.2009.10.017] [PMID: 19846303]
[27]
Dang Thi TA, Kim Tuyet NT, Pham The C, et al. Synthesis and cytotoxic evaluation of novel ester-triazole-linked triterpenoid-AZT conjugates. Bioorg Med Chem Lett 2014; 24(22): 5190-4.
[http://dx.doi.org/10.1016/j.bmcl.2014.09.079] [PMID: 25442310]
[28]
Gao C, Dai FJ, Cui HW, et al. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity. Chem Biol Drug Des 2014; 84(2): 223-33.
[http://dx.doi.org/10.1111/cbdd.12308] [PMID: 24612785]
[29]
de Souza MVN, Pais KC, Kaiser CR, Peralta MA, de L Ferreira M, Lourenço MCS. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives. Bioorg Med Chem 2009; 17(4): 1474-80.
[http://dx.doi.org/10.1016/j.bmc.2009.01.013] [PMID: 19188070]
[30]
Musiol R, Jampilek J, Buchta V, et al. Antifungal properties of new series of quinoline derivatives. Bioorg Med Chem 2006; 14(10): 3592-8.
[http://dx.doi.org/10.1016/j.bmc.2006.01.016] [PMID: 16458522]
[31]
Verma A, Prateek P, Thakur A, Shukla PK. Piperazine bridged 4-aminoquinoline 1,3,5- triazine derivatives: Design, Synthesis, characterization and antibacterial evaluation. Int J Chemtech Res 2016; 9: 261-9.
[32]
Thakur A, Gupta PS, Pathak P. Design, Synthesis, SAR, Docking and antibacterial evaluation: Aliphatic amide bridged 4-aminoquinoline clubbed 1, 2, 4- triazole derivatives. Int J Chemtech Res 2016; 9: 575-88.
[33]
Ranjbar-Karimi R, Poorfreidoni A. Incorporation of fluorinated pyridine in the side chain of 4 - aminoquinolines: Synthesis, characterization and antibacterial activity. Drug Res (Stuttg) 2018; 68(1): 17-22.
[http://dx.doi.org/10.1055/s-0043-116674] [PMID: 28847024]
[34]
Bhat HR, Masih A, Shakya A, Kumar S. Design, synthesis, anticancer, antibacterial, and antifungal evaluation of 4-aminoquinoline-1, 3, 5-triazine derivatives. J Heterocycl Chem 2020; 57: 390-9.
[http://dx.doi.org/10.1002/jhet.3791]
[35]
Manohar S, Pepe A, Christian EV, Zayas B. Anticancer activity of 4-aminoquinoline-triazine based molecular hybrids. RSC Advances 2014; 4: 7062-7.
[http://dx.doi.org/10.1039/c3ra45333b]
[36]
Kandi SK, Manohar S, Christian EV, Zayas B, Malhotra SV, Rawat DS. C5-curcuminoid-4-aminoquinoline based molecular hybrids: design, synthesis and mechanistic investigation of anticancer activity. New Engl J Chem 2015; 39: 224-34.
[http://dx.doi.org/10.1039/C4NJ00936C]
[37]
Solomon VR, Pundir S, Lee H. Examination of novel 4-aminoquinoline derivatives designed and synthesized by a hybrid pharmacophore approach to enhance their anticancer activities. Sci Rep 2019; 9(1): 6315.
[http://dx.doi.org/10.1038/s41598-019-42816-4] [PMID: 31004122]
[38]
Yadav DK, Rai R, Kumar N, et al. New arylated benzo[h]quinolines induce anti-cancer activity by oxidative stress-mediated DNA damage. Sci Rep 2016; 6: 38128.
[http://dx.doi.org/10.1038/srep38128] [PMID: 27922047]
[39]
Anderson E, Jiang X, Liu X, Visnick M. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring. WIPO Patent, WO2009129545A1, 2009.
[40]
Rong F, Xu R, Xie F, Lai H. Oleanolic acid amidate derivatives, preparation methods and uses thereof. European Patent, EP2787002A1, 2014.
[41]
Gary B, William CB, Hotema Martha R, et al. C4- Modified oleanolic acid derivatives for inhibition of IL-17 and other uses. European Patent, EP3353190A1, 2018.
[42]
Naglah AM, Amr AE, Al-Omar MA. Oleanolic acid methyl ester derivatives. King Saud University Patents, 9969768, 2018.
[43]
Rali S, Oyedeji OO, Aremu OO, Oyedeji AO, Nkeh-Chungag B N. Semisynthesis of derivatives of oleanolic acid from Syzygium aromaticum and their antinociceptive and anti-inflammatory properties. Mediators Inflamm 2016; 2016: 8401843.
[44]
Nkeh-Chungag BN, Oyedeji OO, Oyedeji AO, Ndebia EJ. Anti-inflammatory and membrane-stabilizing properties of two semisynthetic derivatives of oleanolic acid. Inflammation 2015; 38(1): 61-9.
[http://dx.doi.org/10.1007/s10753-014-0007-y] [PMID: 25173889]
[45]
Hossain MA, Zhari I. Isolation and characterization of triterpenes from the leaves of Orthosiphon stamineus. Arab J Chem 2013; 6: 295-8.
[http://dx.doi.org/10.1016/j.arabjc.2010.10.009]
[46]
Sunduru N, Sharma M, Srivastava K, et al. Synthesis of oxalamide and triazine derivatives as a novel class of hybrid 4-aminoquinoline with potent antiplasmodial activity. Bioorg Med Chem 2009; 17(17): 6451-62.
[http://dx.doi.org/10.1016/j.bmc.2009.05.075] [PMID: 19665899]
[47]
Musonda CC, Gut J, Rosenthal PJ, Yardley V, Carvalho de Souza RC, Chibale K. Application of multicomponent reactions to antimalarial drug discovery. Part 2: New antiplasmodial and antitrypanosomal 4-aminoquinoline gamma- and delta-lactams via a ‘catch and release’ protocol. Bioorg Med Chem 2006; 14(16): 5605-15.
[http://dx.doi.org/10.1016/j.bmc.2006.04.035] [PMID: 16690319]
[48]
Kavitha N, Karthia A, Arun A, Syed Shafi S. Synthesis, characterization and antimicrobial activity of some novel s-triazine derivatives incorporating quinoline moiety. Acta Chim Pharm India 2016; 6: 53-61.
[49]
Pretorius SI, Breytenbach WJ, de Kock C, Smith PJ, N’Da DD. Synthesis, characterization and antimalarial activity of quinoline-pyrimidine hybrids. Bioorg Med Chem 2013; 21(1): 269-77.
[http://dx.doi.org/10.1016/j.bmc.2012.10.019] [PMID: 23168082]
[50]
Smit FJ, N’Da DD. Synthesis and in vitro antimalarial activity of novel chalcone derivatives 2014. Available from: https://dspace.nwu.ac.za/handle/10394/12262 ?show=full
[51]
Pretorius IS, N’Da DD. Synthesis, characterisation and antimalarial activity of quinoline-pyrimidine hybrids, Masters of science. Pharmaceutical Chemistry, North-West University 2012.
[52]
Fonkui TY, Ikhile MI, Ndinteh DT, Njobeh PB. Schiff bases: synthesis, characterization and antimicrobial properties. Doctores Technologiae in Biotechnology, University of Johannesburg 2018.
[53]
Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 2006; 1(3): 1112-6.
[http://dx.doi.org/10.1038/nprot.2006.179] [PMID: 17406391]
[54]
Kavitha N, Arun A, Syed Shafi S. Synthesis, characterization and antimicrobial activity of some novel s- triazine derivatives incorporating quinoline moiety. Der Pharma Chem 2015; 7: 453-8.
[55]
Martins A, Vasas A, Viveiros M, Molnár J, Hohmann J, Amaral L. Antibacterial properties of compounds isolated from Carpobrotus edulis. Int J Antimicrob Agents 2011; 37(5): 438-44.
[http://dx.doi.org/10.1016/j.ijantimicag.2011.01.016] [PMID: 21411294]
[56]
Grudniak AM, Kurek A, Szarlak J, Wolska KI. Oleanolic and ursolic acids influence affect the expression of the cysteine regulon and the stress response in Escherichia coli. Curr Microbiol 2011; 62(4): 1331-6.
[http://dx.doi.org/10.1007/s00284-010-9866-0] [PMID: 21221969]
[57]
Kurek A, Grudniak AM, Szwed M, et al. Oleanolic acid and ursolic acid affect peptidoglycan metabolism in Listeria monocytogenes. Antonie van Leeuwenhoek 2010; 97(1): 61-8.
[http://dx.doi.org/10.1007/s10482-009-9388-6] [PMID: 19894138]
[58]
Byrd TF, Horwitz MA. Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest 1991; 88(1): 351-7.
[http://dx.doi.org/10.1172/JCI115301] [PMID: 2056129]
[59]
Malléa M, Mahamoud A, Chevalier J, et al. Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. Biochem J 2003; 376(Pt 3): 801-5.
[http://dx.doi.org/10.1042/bj20030963] [PMID: 12959639]
[60]
Zannoni D. Mefloquine: an antimalarial drug interacting with the b/c region of bacterial respiratory chains. FEBS Lett 1985; 183: 340-4.
[http://dx.doi.org/10.1016/0014-5793(85)80806-1]
[61]
Khusnutdinova EF, Petrova AV, Thu HNT, et al. Structural modifications of 2,3-indolobetulinic acid: Design and synthesis of highly potent α-glucosidase inhibitors. Bioorg Chem 2019; 88: 102957.
[http://dx.doi.org/10.1016/j.bioorg.2019.102957] [PMID: 31077913]
[62]
Pattnaik B, Lakshma Nayak V, Ramakrishna S, Venkata Mallavadhani U. Synthesis of ring-C modified oleanolic acid derivatives and their cytotoxic evaluation. Bioorg Chem 2016; 68: 152-8.
[http://dx.doi.org/10.1016/j.bioorg.2016.08.001] [PMID: 27522460]
[63]
Hao J, Liu J, Wen X, Sun H. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives. Bioorg Med Chem Lett 2013; 23(7): 2074-7.
[http://dx.doi.org/10.1016/j.bmcl.2013.01.129] [PMID: 23434227]
[64]
Akl MR, Elsayed HE, Ebrahim HY, Haggag EG, Kamal AM, El Sayed KA. 3-O-[N-(p-fluorobenzenesulfonyl)-carbamoyl]-oleanolic acid, a semisynthetic analog of oleanolic acid, induces apoptosis in breast cancer cells. Eur J Pharmacol 2014; 740: 209-17.
[http://dx.doi.org/10.1016/j.ejphar.2014.07.011] [PMID: 25046839]
[65]
Wu J, Yang C, Guo C, et al. SZC015, a synthetic oleanolic acid derivative, induces both apoptosis and autophagy in MCF-7 breast cancer cells. Chem Biol Interact 2016; 244: 94-104.
[http://dx.doi.org/10.1016/j.cbi.2015.11.013] [PMID: 26612655]

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy